|Bid||17.50 x 200|
|Day's Range||22.52 - 22.91|
|52 Week Range||18.68 - 30.80|
|PE Ratio (TTM)||-316.39|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Q1 2017 NxStage Medical Inc Earnings Call
A cut in 2017 outlook for home dialysis products has investors disappointed.
First-quarter results for the dialysis services company were solid, but the key home market isn't doing as well as hoped.